Phase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic Melanoma
Clinical trial NCT00679289 · COMPLETED
Trial details
- NCT number
- NCT00679289
- Sponsor
- Ludwig Institute for Cancer Research
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-28
- Primary completion
- 2014-02-03
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.